John W. Bristol & Co’s Amgen AMGN Stock Holding History

John W. Bristol & Co’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,362	Closed	-$290K	–	89
2021 Q3	$290K	Hold	1,362	–	–	0.01%	86
2021 Q2	$332K	Hold	1,362	–	–	0.01%	85
2021 Q1	$339K	Sell	1,362 -88	-6%	-$21K	0.01%	81
2020 Q4	$333K	Hold	1,450	–	–	0.01%	73
2020 Q3	$369K	Hold	1,450	–	–	0.01%	67
2020 Q2	$342K	Hold	1,450	–	–	0.01%	53
2020 Q1	$294K	Hold	1,450	–	–	0.01%	50
2019 Q4	$350K	Hold	1,450	–	–	0.01%	60
2019 Q3	$281K	Hold	1,450	–	–	0.01%	61
2019 Q2	$267K	Hold	1,450	–	–	0.01%	60
2019 Q1	$275K	Hold	1,450	–	–	0.01%	61
2018 Q4	$282K	Buy	+1,450	New	+$283K	0.01%	64

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

John W. Bristol & Co's AMGN Position: Q4 2021 in Review

John W. Bristol & Co sold out of Amgen (AMGN) in Q4 2021, closing a stake of 1,362 shares — an estimated $290K sold.

John W. Bristol & Co first reported a position in AMGN in Q4 2018 and held it in 12 quarters. The position peaked at $369K in Q3 2020. 2,293 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

John W. Bristol & Co reported no remaining Amgen position as of Q4 2021 after selling out during the quarter.
John W. Bristol & Co sold 1,362 Amgen shares in Q4 2021, an estimated $290K.
John W. Bristol & Co first reported a position in Amgen in Q4 2018 and held it in 12 quarters.
John W. Bristol & Co's Amgen position peaked at $369K in Q3 2020.
2,293 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on John W. Bristol & Co's 13F filing for Q4 2021, filed 31 Jan 2022.